Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hemoglobin variability and mortality in ESRD.

Wei Yang1, Rubeen K Israni, Steven M Brunelli

  • 1Center for Clinical Epidemiology and Biostatistics and the Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.

Journal of the American Society of Nephrology : JASN
|November 16, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Five-Year Risk Prediction Models for Peripheral Artery Disease in Patients With Chronic Kidney Disease.

Kidney medicine·2026
Same author

Oral iptacopan therapy in patients with C3 glomerulopathy: a randomised, double-blind, parallel group, multicentre, placebo-controlled, phase 3 study.

Lancet (London, England)·2025
Same author

Deoxycholic Acid and Cognitive Impairment and Decline in the Chronic Renal Insufficiency Cohort (CRIC).

Kidney medicine·2025
Same author

Family History in the Context of CKD.

Journal of the American Society of Nephrology : JASN·2025
Same author

Selection of number of clusters and warping penalty in clustering functional electrocardiogram.

Statistics in medicine·2024
Same author

Matrix Metalloproteinase-2 and CKD Progression: The Chronic Renal Insufficiency Cohort (CRIC) Study.

Kidney medicine·2024
Same journal

Variants to Functions to Therapeutic Strategies Toward Genomically Informed Care for Autosomal Dominant Polycystic Kidney Disease.

Journal of the American Society of Nephrology : JASN·2026
Same journal

Personalizing Cardio-Kidney-Metabolic Therapy: Closer But Not There Yet.

Journal of the American Society of Nephrology : JASN·2026
Same journal

Autosomal Dominant Tubulointerstitial Kidney Disease: My Kingdom for a Biomarker.

Journal of the American Society of Nephrology : JASN·2026
Same journal

Beyond the Margin: Improving Noninferiority Trials of Kidney Transplant Immunosuppression.

Journal of the American Society of Nephrology : JASN·2026
Same journal

Parathyroid Hormone Receptor 1 Facilitates Cyst Growth in Genetic Models of Autosomal Dominant Polycystic Kidney Disease.

Journal of the American Society of Nephrology : JASN·2026
Same journal

Alanyl-tRNA Synthetase 1 and Cyst Growth in Autosomal Dominant Polycystic Kidney Disease.

Journal of the American Society of Nephrology : JASN·2026
See all related articles

High hemoglobin variability in hemodialysis patients is linked to increased mortality risk. This study found that greater fluctuations in hemoglobin levels, independent of average levels or trends, predict a higher chance of death.

Area of Science:

  • Nephrology
  • Hematology
  • Clinical Epidemiology

Background:

  • Hemoglobin levels fluctuate significantly in patients undergoing hemodialysis.
  • This variability is a potential indicator of adverse health outcomes.
  • Understanding different measures of hemoglobin over time is crucial for patient management.

Purpose of the Study:

  • To investigate the independent associations of absolute hemoglobin levels, rate of change, and variability with mortality.
  • To analyze these associations in a large cohort of hemodialysis patients.
  • To determine if hemoglobin variability is an independent predictor of mortality.

Main Methods:

  • Retrospective cohort study of 34,963 hemodialysis patients.
  • Linear regression modeled individual hemoglobin concentration over time (intercept, slope).

Related Experiment Videos

  • Residual standard deviation quantified hemoglobin variability; survival analyses assessed mortality risk.

    • Main Results:

    • Each 1g/dl increase in hemoglobin variability (residual standard deviation) was associated with a 33% increase in the rate of death.
    • This association remained significant after adjusting for multiple covariates.
    • Patient characteristics explained only a small fraction (R2 = 0.019) of the variation in hemoglobin variability.

    Conclusions:

    • Increased hemoglobin variability is independently associated with higher mortality in hemodialysis patients.
    • Hemoglobin variability is a significant predictor of mortality, beyond average levels or trends.
    • This finding highlights the importance of monitoring hemoglobin fluctuations in this patient population.